Tumor profiling of 431 pancreatic tumors from elderly patients | Caris Life Sciences
Portal
Order
Home / Research / Publications / Tumor profiling of 431 pancreatic tumors from elderly patients

Publications

Back

Tumor profiling of 431 pancreatic tumors from elderly patients

– Caris Life Sciences

Poster

Background

Pancreatic cancer (PC) is frequently a disease of the elderly and controversy exists as to whether these patients benefit from aggressive treatments. We aimed to investigate biomarker features from tumors taken from elderly PC patients to identify therapeutic implications. We also compared the results to those from younger patients to assess differences.

Download Publication

Discover
More

  • Alterations in targetable molecular pathways are enriched in KRAS wild-type (WT) pancreatic cancer (PC)

    – Caris Life Sciences

    Poster

    Conclusions: KRAS WT PC is significantly more enriched with targetable alterations (e.g., BRAF, ALK, ROS1, NRG1, MSI-H) as compared to KRAS MT tumors, suggesting potential… […]

  • A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients With Non-Pancreatic Neuroendocrine Tumors

    – Caris Life Sciences

    Manuscript

    Purpose: Immune checkpoint blockade has improved outcomes across tumor types; little is known about the efficacy of these agents in rare tumors. We report the… […]
Learn More

Ready to Get Started on the Journey?

Name(Required)